Financial Report: Catalent

Clinical Services up 22% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent   2Q Revenues: $454.9 million (flat) 2Q Earnings: $30.6 million (-33%) YTD Revenues: $877.9 million (flat) YTD Earnings: $39.5 million (+51%) Comments: Revenue from the Oral Technologies segment was $255.1 million in the quarter, down 8%, attributable to the temporary suspension of operations of the Beinheim facility, lower demand for certain modified release technologies, partially offset by increased demand for certain softgel products. Revenue from the Development and C...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters